Date: 2016-07-19
Type of information: Construction of new premises
Compound: new campus in Burlington, Massachusetts
Company: Merck KGaA (Germany)
Therapeutic area: Technology - Services
Type agreement: construction of new premises
Action mechanism:
Disease:
Details: * On July 19, 2016, Merck KGaA announced plans to build a new campus in Burlington, Massachusetts that will serve as
a major hub for the North American life science business of Merck. The 280,000-square-foot facility will include a customer collaboration laboratory and training center as well as office space. The campus will serve as a premier global customer destination, housing both a customer service and call center and an M Lab™ Collaboration Center—a state-of-the-art, shared, exploratory environment where the company’s scientists and engineers work together with customers to help solve their toughest life science challenges. The M Lab™ Collaboration Center will be one of nine centers worldwide created specifically for collaboration, where hands-on training, customer experiments and application troubleshooting take place in a non-GMP environment. Other locations will include Brazil, China, France, India, Singapore and South Korea. This new enhanced M Lab™ center in Burlington, Massachusetts will replace the flagship M Lab™ at the company’s Billerica, Massachusetts facility. Merck’s 850 full-time Billerica-based life science employees will relocate to the new campus when construction is complete in the second half of 2017.
The $115 million (€104 million) building will be LEED certified. The LEED (Leadership in Energy and Environmental Design) rating system is the most widely used third-party verification for green construction, certifying buildings that promote sustainability, resource conservation and human health. The five-story, single-tenant building near Route 3 and Route 128 in Burlington is being built by The Gutierrez Company. The project includes an opportunity to expand an
additional 70,000 square feet. Merck leases the property. Merck will maintain its other North American life science hub in St. Louis, Missouri.
Financial terms:
Latest news:
